IL5 and chronic obstructive pulmonary disease: GATA-3 DNAzyme is being explored in other airway diseases such as chronic obstructive pulmonary disease (COPD), where inhalation of 10 mg SB010 bid for 28 days in COPD patients significantly reduced sputum eosinophilia with a trend to lower IL-5 levels [129].